ENZC New PATENT APPLICATION 20 YR revenue stream!?HIV $30 BILLION MARKET & case study update??

Click here for the video version of this post:

Enzolytics’ new patent application, once approved, would have the potential for a generous 20-year revenue stream for the company! ENZC is a compelling OTC stock because of their focus on delivering safe, more effective, therapeutics for dangerous viruses like COVID and HIV.

Here you will also get an update on ENZC’s HIV therapeutic trials in Africa that addresses the $30 billion HIV market. This video also covers what you should look out for when investing in this stock. We take a look at Enzolytics’ stock chart, short float and security details. Watch the video to discover the details!